Studies on Pharmacokinetics of Rhubarb Acid Enteric-coated Sustained-release Pellets in Rabbits
Can Jin
Abstract
Can Jin
Abstract
Objective:To study the pharmacokinetics and bioequivalence of self-prepared rhubarb acid enteric-coated sustained-release pellets,and compare the pharmacokinetics of rhein between rhubarb acid enteric-coated sustained-release pellets and solution,make clear the pharmacokinetic character of the sustained release preparation in vivo.Method:Ten rabbits were given a single oral dose of 35 mg·kg-1 of self-prepared rhubarb acid enteric-coated sustained-release pellets(test preparation) and the sodium alginate solution of rhein(reference preparation) in a crossover study.HPLC was applied to determine the plasma concentrations of rhein before and 0.5,1,2,3,4,6,8,9,10,12,24,28,32,36 h after administration of the medicine.The pharmacokinetic parameters were calculatedand statistically analyzed.Result:The plasma concentration curves of both the sustained-release matrix pellets and the sodium alginate solution of rhein had one peak.The main pharmacokinetic parameters of test preparation were as follows:tmax(9.73±0.68)h,Cmax(3.00±0.81) g·L-1,AUC0~∞(59.21±4.35) mg·L-1·h-1,MRT(21.12±1.12)h;and those of reference preparation were as follows:tmax(4.17±0.12)h,cmax(2.71±0.74) g·L-1,AUC0~∞(39.72±3.11) mg·L-1·h-1,MRT(9.33±2.08)h respectively.Conclusion:Compared with the sodium alginate solution of rhein,the self-prepared rhubarb acid enteric-coated sustained-release pellets have better bioavailability.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the pharmacokinetics and bioequivalence of self-prepared rhubarb acid enteric-coated sustained-release pellets,and compare the pharmacokinetics of rhein between rhubarb acid enteric-coated sustained-release pellets and solution,make clear the pharmacokinetic character of the sustained release preparation in vivo.Method:Ten rabbits were given a single oral dose of 35 mg·kg-1 of self-prepared rhubarb acid enteric-coated sustained-release pellets(test preparation) and the sodium alginate solution of rhein(reference preparation) in a crossover study.HPLC was applied to determine the plasma concentrations of rhein before and 0.5,1,2,3,4,6,8,9,10,12,24,28,32,36 h after administration of the medicine.The pharmacokinetic parameters were calculatedand statistically analyzed.Result:The plasma concentration curves of both the sustained-release matrix pellets and the sodium alginate solution of rhein had one peak.The main pharmacokinetic parameters of test preparation were as follows:tmax(9.73±0.68)h,Cmax(3.00±0.81) g·L-1,AUC0~∞(59.21±4.35) mg·L-1·h-1,MRT(21.12±1.12)h;and those of reference preparation were as follows:tmax(4.17±0.12)h,cmax(2.71±0.74) g·L-1,AUC0~∞(39.72±3.11) mg·L-1·h-1,MRT(9.33±2.08)h respectively.Conclusion:Compared with the sodium alginate solution of rhein,the self-prepared rhubarb acid enteric-coated sustained-release pellets have better bioavailability.
Key concepts: Pharmacokinetics, Cmax, Pellets, Bioequivalence, Bioavailability, Enteric coated, Chemistry, Chromatography